Documents & Downloads

MP-PEG8-Val-Lys-Gly-7-MAD-MDCPT

Drug-linker Conjugate of ADC

MP-PEG8-Val-Lys-Gly-7-MAD-MDCPT is an antibody-drug conjugate (ADC) drug-linker designed for targeted cancer therapy. This compound comprises the cytotoxic payload 7-MAD-MDCPT linked through the MP-PEG8-Val-Lys-Gly scaffold. It is utilized to enhance the selective delivery of therapeutic agents to cancer cells, thereby improving efficacy and reducing off-target effects in research applications related to oncology and drug development.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
CAS Number	2378428-24-9
Applications	Drug-linker Conjugate of ADC
Formula	C₆₁H₈₅N₉O₂₁
Molecular Weight	1280.38
SMILES	O=C(C=CC1=O)N1CCC(NCCOCCOCCOCCOCCOCCOCCOCCOCCC(N[C@@H](C(C)C)C(N[C@@H](CCCCN)C(NCC(NCC2=C3C(C(N4C3)=CC([C@](O)(C(OC5)=O)CC)=C5C4=O)=NC6=CC(OCO7)=C7C=C62)=O)=O)=O)=O)=O

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.